John F. Callan

8.6k total citations · 2 hit papers
101 papers, 6.6k citations indexed

About

John F. Callan is a scholar working on Biomedical Engineering, Materials Chemistry and Spectroscopy. According to data from OpenAlex, John F. Callan has authored 101 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Biomedical Engineering, 39 papers in Materials Chemistry and 31 papers in Spectroscopy. Recurrent topics in John F. Callan's work include Molecular Sensors and Ion Detection (31 papers), Nanoplatforms for cancer theranostics (30 papers) and Ultrasound and Hyperthermia Applications (25 papers). John F. Callan is often cited by papers focused on Molecular Sensors and Ion Detection (31 papers), Nanoplatforms for cancer theranostics (30 papers) and Ultrasound and Hyperthermia Applications (25 papers). John F. Callan collaborates with scholars based in United Kingdom, United States and India. John F. Callan's co-authors include A. P. McHale, A. Prasanna de Silva, David C. Magri, Colin Fowley, Nikolitsa Nomikou, Bridgeen McCaughan, Suban K. Sahoo, Navneet Kaur, Darshna Sharma and Rati Kanta Bera and has published in prestigious journals such as Journal of the American Chemical Society, Chemical Society Reviews and SHILAP Revista de lepidopterología.

In The Last Decade

John F. Callan

101 papers receiving 6.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Luminescent sensors and switches in the early 21st century

2005 1.0k citations John F. Callan et al. profile →
Iron(iii) selective molecular and supramolecular fluorescent probes

2012 707 citations Suban K. Sahoo, John F. Callan et al. profile →

Peers

Countries citing papers authored by John F. Callan

Since Specialization

Citations

This map shows the geographic impact of John F. Callan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John F. Callan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John F. Callan more than expected).

Fields of papers citing papers by John F. Callan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John F. Callan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John F. Callan. The network helps show where John F. Callan may publish in the future.

Co-authorship network of co-authors of John F. Callan

This figure shows the co-authorship network connecting the top 25 collaborators of John F. Callan. A scholar is included among the top collaborators of John F. Callan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John F. Callan. John F. Callan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Non-Invasive, Targeted Nanoparticle-Mediated Drug Delivery across a Novel Human BBB Model 2023 ·Pharmaceutics ·(unknown), John F. Callan, Susan Hawthorne	6
2	Exploiting a Rose Bengal-bearing, oxygen-producing nanoparticle for SDT and associated immune-mediated therapeutic effects in the treatment of pancreatic cancer 2021 ·European Journal of Pharmaceutics and Biopharmaceutics ·Dean Nicholas, Heather Nesbitt, (unknown), (unknown), (unknown), (unknown), Paul Kelly, Declan O’Rourke, Simon Porter, Keith Thomas, Barry O’Hagan, Nikolitsa Nomikou, John F. Callan, A. P. McHale	32
3	Sonodynamic therapy complements PD-L1 immune checkpoint inhibition in a murine model of pancreatic cancer 2021 ·Cancer Letters ·Heather Nesbitt, Keiran Logan, Keith Thomas, John F. Callan, (unknown), (unknown), Mark Taylor, Mark Love, Eleanor Stride, A. P. McHale	41
4	Synthesis of a gemcitabine-modified phospholipid and its subsequent incorporation into a single microbubble formulation loaded with paclitaxel for the treatment of pancreatic cancer using ultrasound-targeted microbubble destruction 2021 ·European Journal of Pharmaceutics and Biopharmaceutics ·Keiran Logan, Heather Nesbitt, John F. Callan, (unknown), (unknown), Mark Taylor, Mark Love, A. P. McHale, John F. Callan	14
5	Ultrasound-Mediated Gemcitabine Delivery Reduces the Normal-Tissue Toxicity of Chemoradiation Therapy in a Muscle-Invasive Bladder Cancer Model 2021 ·International Journal of Radiation OncologyBiologyPhysics ·Jia-Ling Ruan, Richard J. Browning, (unknown), Michael Gray, Luca Baù, Sukanta Kamila, James Thompson, (unknown), Sean Smart, A. P. McHale, John F. Callan, Borivoj Vojnovic, Eleanor Stride, Anne E. Kiltie	13
6	A single microbubble formulation carrying 5-fluorouridine, Irinotecan and oxaliplatin to enable FOLFIRINOX treatment of pancreatic and colon cancer using ultrasound targeted microbubble destruction 2021 ·Journal of Controlled Release ·(unknown), Keiran Logan, Heather Nesbitt, John F. Callan, (unknown), Mark Taylor, Mark Love, A. P. McHale, Darren M. Griffith	23
7	Rose Bengal–Amphiphilic Peptide Conjugate for Enhanced Photodynamic Therapy of Malignant Melanoma 2020 ·Journal of Medicinal Chemistry ·(unknown), (unknown), (unknown), Yingjie Sheng, (unknown), (unknown), B.C. White, Heather Nesbitt, Rubeta Matin, A. P. McHale, John F. Callan, John F. Callan	41
8	An ultrasound responsive microbubble-liposome conjugate for targeted irinotecan-oxaliplatin treatment of pancreatic cancer 2020 ·European Journal of Pharmaceutics and Biopharmaceutics ·(unknown), Heather Nesbitt, Keiran Logan, (unknown), B.C. White, (unknown), Mark Taylor, Mark Love, John F. Callan, A. P. McHale	28
9	Direct Evidence of Multibubble Sonoluminescence Using Therapeutic Ultrasound and Microbubbles 2019 ·ACS Applied Materials & Interfaces ·Estelle Beguin, S. K. Shrivastava, Н. В. Дежкунов, A. P. McHale, John F. Callan, Eleanor Stride	81
10	Magnetic microbubble mediated chemo-sonodynamic therapy using a combined magnetic-acoustic device 2019 ·Journal of Controlled Release ·Estelle Beguin, Michael Gray, Keiran Logan, Heather Nesbitt, Yingjie Sheng, Sukanta Kamila, Lester C. Barnsley, Luca Baù, A. P. McHale, John F. Callan, Eleanor Stride	43
11	Electroneutral polymersomes for combined cancer chemotherapy 2018 ·Acta Biomaterialia ·Noorjahan Aibani, Heather Nesbitt, (unknown), (unknown), (unknown), (unknown), (unknown), Yingjie Sheng, (unknown), Susan Hawthorne, A. P. McHale, John F. Callan, John F. Callan	21
12	The integration of triggered drug delivery with real time quantification using FRET; creating a super ‘smart’ drug delivery system 2017 ·Journal of Controlled Release ·Noorjahan Aibani, (unknown), (unknown), (unknown), Françisco M. Raymo, John F. Callan	17
13	Oxygen generating nanoparticles for improved photodynamic therapy of hypoxic tumours 2017 ·Journal of Controlled Release ·Yingjie Sheng, Heather Nesbitt, John F. Callan, Mark Taylor, Mark Love, A. P. McHale	98
14	Cathepsin B-degradable, NIR-responsive nanoparticulate platform for target-specific cancer therapy 2016 ·Nanotechnology ·Sam P. Tarassoli, (unknown), Hayley Pye, Charles A. Mosse, John F. Callan, Alexander J. MacRobert, A. P. McHale, Nikolitsa Nomikou	18
15	Pyridoxal derived chemosensor: Its application in anion sensing and molecular logic gate building 2015 ·John F. Callan, Suban K. Sahoo, (unknown), Shilpa Bothra, (unknown), Selva Kumar Ramasamy, (unknown), (unknown), (unknown)	2
16	Oxygen carrying microbubbles for enhanced sonodynamic therapy of hypoxic tumours 2015 ·Journal of Controlled Release ·Conor McEwan, Joshua Owen, Eleanor Stride, Colin Fowley, Heather Nesbitt, David E. Cochrane, Constantin Coussios, Mark A. Borden, Nikolitsa Nomikou, A. P. McHale, John F. Callan	236
17	Highly luminescent biocompatible carbon quantum dots by encapsulation with an amphiphilic polymer 2012 ·Chemical Communications ·Colin Fowley, Bridgeen McCaughan, (unknown), İbrahim Yıldız, Françisco M. Raymo, John F. Callan	55
18	Fluorescent Recognition of Potassium and Calcium Ions Using Functionalised CdSe / ZnS Quantum Dots 2009 ·Journal of Fluorescence ·Narinder Singh, Ray C. Mulrooney, Navneet Kaur, John F. Callan	21
19	Luminescent Detection of ATP in Aqueous Solution Using Positively Charged CdSe–ZnS Quantum Dots 2008 ·Journal of Fluorescence ·John F. Callan, Ray C. Mulrooney, Sukanta Kamila	39
20	Anion Sensing with Luminescent Quantum Dots – A Modular Approach Based on the Photoinduced Electron Transfer (PET) Mechanism 2007 ·Journal of Fluorescence ·John F. Callan, Ray C. Mulrooney, Sukanta Kamila, Bridgeen McCaughan	72

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact